histidine has been researched along with nnc0195-0092 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 7 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agersø, H; Højby Rasmussen, M; Juul Kildemoes, R; Overgaard, RV | 1 |
| Bjelke, M; Damholt, BB; Helleberg, H; Pedersen, PJ; Rasmussen, MH | 1 |
| Bjelke, M; Helleberg, H; Lindecrona, RH; Thygesen, P | 1 |
| Battelino, T; Brod, M; Horikawa, R; Højby Rasmussen, M; Saenger, P; Sävendahl, L | 1 |
| Biller, BMK; Hollensen, C; Johannsson, G; Kildemoes, RJ; Rasmussen, MH; Takahashi, Y | 1 |
| Miller, BS; Yuen, KCJ | 1 |
| Miller, BS | 1 |
2 review(s) available for histidine and nnc0195-0092
| Article | Year |
|---|---|
Spotlight on Lonapegsomatropin Once-Weekly Injection and Its Potential in the Treatment of Growth Hormone Deficiency in Pediatric Patients.
Topics: Adult; Child; Dwarfism, Pituitary; Histidine; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Mannitol; Phenol; Quality of Life; United States | 2022 |
What do we do now that the long-acting growth hormone is here?
Topics: Adult; Child; Dwarfism, Pituitary; Growth Hormone; Histidine; Human Growth Hormone; Humans; Mannitol; Phenol; Quality of Life; United States | 2022 |
3 trial(s) available for histidine and nnc0195-0092
| Article | Year |
|---|---|
Absorption, metabolism and excretion of once-weekly somapacitan, a long-acting growth hormone derivative, after single subcutaneous dosing in human subjects.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Albumins; Child; Feces; Histidine; Human Growth Hormone; Humans; Male; Mannitol; Phenol; Research Subjects | 2021 |
Effective GH Replacement With Once-weekly Somapacitan vs Daily GH in Children with GHD: 3-year Results From REAL 3.
Topics: Body Height; Child; Dwarfism, Pituitary; Growth Hormone; Histidine; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Mannitol; Phenol; Pituitary Hormones, Anterior | 2022 |
Dose-exposure-IGF-I response of once-weekly somapacitan in adults with GH deficiency.
Topics: Adult; Dwarfism, Pituitary; Estrogens; Female; Histidine; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Mannitol; Phenol; Pituitary Hormones, Anterior | 2022 |
2 other study(ies) available for histidine and nnc0195-0092
| Article | Year |
|---|---|
Optimal Monitoring of Weekly IGF-I Levels During Growth Hormone Therapy With Once-Weekly Somapacitan.
Topics: Adult; Child; Clinical Trials, Phase I as Topic; Drug Administration Schedule; Drug Monitoring; Follow-Up Studies; Growth Disorders; Histidine; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Mannitol; Phenol; Prognosis; Randomized Controlled Trials as Topic; Retrospective Studies; Tissue Distribution | 2021 |
Structure identification of circulating metabolites from somapacitan, a long-acting growth hormone derivative, and pharmacokinetics after single and multiple subcutaneous dosing in rats.
Topics: Animals; Chromatography, High Pressure Liquid; Dwarfism, Pituitary; Female; Growth Hormone; Histidine; Human Growth Hormone; Male; Mannitol; Phenol; Plasma; Rats | 2022 |